Multiple myeloma with t(11;14): impact of novel agents on outcome.

Blood Cancer J · 2023 · PMC10025259 · PMID 36935422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In our series, patients from the t (11;14) group treated with novel agents showed a trend towards better response and survival.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.